Cardiology Clinical Trials in Redmond, WA
As of July 2026, 4 paid clinical trials are recruiting for Cardiology in Redmond, Washington. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Redmond
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
5 clinical trials for Cardiology
·Clear filters·↓ Download CSVEfficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Top Research Study Locations in Redmond
Researchers run research studies in Redmond, WA at 5 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Eastside Research Associates | Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD), COVID-19 SARS-CoV-2 Infection | 8 |
| ERA Health Research | Diabetes, Type 2, Obesity, Overweight | 2 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Eastside Research Associates Health Research | Obesity or Overweight | 1 |
| Eastside Research Associates, LLC dba Era Health Research | Atherosclerosis | 1 |
Active & Upcoming Studies in Redmond (2026)
Recruiting trials in Redmond grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (5 active studies)
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH) · Phase 3 · Amgen
Vaccines (2 active studies)
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Cardiovascular (2 active studies)
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin · Phase 3 · AstraZeneca
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) · Phase 3 · Anthos Therapeutics, Inc.
Mental health & behavior (1 active study)
- A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse · Phase 2 · Eli Lilly and Company
Common conditions studied in Redmond
- Atherosclerosis (2 active studies)
- Obesity or Overweight (2 active studies)
- Type 2 Diabetes (2 active studies)
- Type 2 Diabetes Mellitus (2 active studies)
- Atherosclerotic Cardiovascular Disease (ASCVD) (1 active study)
- Atrial Fibrillation (AF) (1 active study)
Leading research sponsors in Redmond
- Eli Lilly and Company
- AstraZeneca
- Pfizer
- Amgen
- Anthos Therapeutics, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Redmond?
There are approximately 16 recruiting clinical trials in Redmond, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Redmond pay participants?
Most recruiting trials in Redmond compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Redmond?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Redmond?
The most common conditions under active study in Redmond include Atherosclerosis (2), Obesity or Overweight (2), Type 2 Diabetes (2), Type 2 Diabetes Mellitus (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Redmond?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Redmond on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Redmond?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Redmond?
Recruiting research sites in Redmond include Eastside Research Associates, ERA Health Research, Anthos Investigative, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Redmond right now?
The largest active categories in Redmond are Diabetes & metabolic (5), Vaccines (2), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.